[Remote] MSL, Women's Health at Natera

United States

Natera Logo
Not SpecifiedCompensation
Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, Healthcare, Medical Devices, PharmaceuticalsIndustries

Skills

Key technologies and capabilities for this role

Medical Science LiaisonWomen's HealthScientific PresentationsClinical PresentationsReproductive Health TestingNon-invasive Prenatal TestingGenetic TestingHereditary Cancer TestingKey Opinion Leader (KOL) ManagementClinical TrialsResearch InitiativesMedical AffairsScientific Communication

Questions & Answers

Common questions about this position

What is the territory for this MSL position?

The territory covers South Central, including TN, AR, MS, and the Carolinas.

How much travel is required for this role?

The role requires weekly 75% travel with primarily in-person customer-facing meetings, and secondarily virtual meetings.

What qualifications and certifications are required?

Candidates need Genetic counseling Board certification and a Master’s Degree in Genetic Counseling or equivalent from an ABGC approved program; prenatal genetic counseling experience is preferred.

What key skills are needed for this MSL role?

The position requires analytical skills to evaluate complex situations and data, problem-solving abilities in a fast-paced environment with competing priorities, and strategic thinking.

What makes a strong candidate for this MSL position?

Strong candidates will have Genetic counseling Board certification, a relevant Master’s degree, prenatal genetic counseling experience, and skills in analysis, problem-solving, and strategic thinking in fast-paced settings.

Natera

Genetic testing and diagnostics solutions provider

About Natera

Natera focuses on genetic testing and diagnostics, providing advanced solutions for cancer patients, transplant patients, and individuals assessing hereditary health risks. Their main technology is cell-free DNA (cfDNA) testing, which analyzes DNA fragments in the blood to detect minimal traces of cancer and assess organ health. Natera stands out by offering specialized tests like the Signatera ctDNA test and Panorama NIPT, along with genetic counseling services. The company's goal is to improve patient care and health outcomes through accurate genetic testing.

Austin, TexasHeadquarters
2004Year Founded
$149.9MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
1,001-5,000Employees

Benefits

Flexible medical plans
Investment options
Time off
Workplace perks

Risks

Hindenburg report accuses Natera of deceptive sales practices, risking legal challenges.
New Prospera Heart features may face slow adoption by healthcare providers.
Fetal RhD NIPT demand may drop post-RhIg shortage, affecting future sales.

Differentiation

Natera's Signatera test offers personalized ctDNA analysis for cancer patients.
Prospera Heart test uses unique Donor Quantity Score for transplant rejection detection.
Panorama NIPT test is a leader in non-invasive prenatal testing with 2 million tests.

Upsides

Increased adoption of liquid biopsy techniques boosts demand for Natera's cfDNA tests.
AI integration enhances accuracy and speed of Natera's cfDNA analysis.
Growing personalized medicine trend aligns with Natera's customized genetic tests.

Land your dream remote job 3x faster with AI